Skip to main content

Table 4 FH of malignant tumor in first degree relatives and survival from UGI cancer *

From: Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China

  

ESCC

GCA

GNCA

 

FH

Case

Death

HR (95% CI)

Case

Death

HR (95% CI)

Case

Death

HR (95% CI)

Any malignant tumor

-

379

232

1

384

278

1

210

134

1

 

+

190

113

1.09(0.86–1.36)

146

96

0.80(0.63–1.01)

85

60

1.22(0.88–1.68)

Any UGI cancer

-

443

268

1

434

309

1

245

164

1

 

+

126

77

1.06(0.82–1.38)

96

65

0.82(0.62–1.08)

50

30

0.85(0.56–1.28)

0 affected

-

443

268

1

434

309

1

245

164

1

1 affected

+

109

69

1.15(0.88–1.50)

82

55

0.80(0.60–1.07)

43

23

0.73(0.46–1.15)

≥2 affected

+

17

8

0.64(0.32–1.30)

14

10

0.94(0.48–1.84)

7

7

1.82(0.84–3.97)

<50

+

23

19

1.82(1.01–3.29)

8

7

2.30(0.85–6.20)

16

8

0.96(0.38–2.38)

>=50

+

103

58

0.92(0.68–1.22)

88

58

0.76(0.57–1.02)

34

22

0.78(0.49–1.26)

Esophageal cancer

-

479

291

1

481

342

1

268

174

1

 

+

90

54

0.97(0.72–1.31)

49

32

0.81(0.56–1.18)

27

20

1.03(0.63–1.68)

Gastric cardia cancer

-

546

327

1

504

356

1

284

189

1

 

+

23

18

1.61(0.99–2.61)

26

18

0.88(0.54–1.42)

11

5

0.66(0.26–1.64)

Gastric noncardia cancer

-

550

336

1

503

356

1

279

185

1

 

+

19

9

0.80(0.41–1.56)

27

18

0.76(0.47–1.22)

16

9

0.96(0.48–1.91)

Non-UGI cancer

-

505

309

1

480

343

1

260

164

1

 

+

64

36

1.10(0.77–1.56)

50

31

0.82(0.56–1.20)

35

30

1.73(1.16–2.60)

  1. *HRs adjusted for age, gender, geographic region, histologic grade, primary tumor stage, and lymph node metastatsis